三元生物
(301206)
| 流通市值：38.12亿 | | | 总市值：59.20亿 |
| 流通股本：1.30亿 | | | 总股本：2.02亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 317,965,979 | 150,204,941.37 | 712,904,207.78 | 514,923,140.19 |
| 营业收入 | 317,965,979 | 150,204,941.37 | 712,904,207.78 | 514,923,140.19 |
| 二、营业总成本 | 288,093,382.43 | 140,915,661.83 | 694,776,643.89 | 512,885,968.89 |
| 营业成本 | 256,915,517.33 | 123,708,148.18 | 633,728,502.33 | 461,905,205.46 |
| 税金及附加 | 1,721,037.59 | 817,618.09 | 3,126,317.86 | 2,299,966.27 |
| 销售费用 | 4,267,456.32 | 1,683,681.72 | 6,967,383.73 | 4,612,233.07 |
| 管理费用 | 15,294,309.4 | 7,186,420.27 | 19,747,314.16 | 14,802,242.4 |
| 研发费用 | 14,794,149.7 | 9,744,135.17 | 41,232,951.56 | 35,805,522.37 |
| 财务费用 | -4,899,087.91 | -2,224,341.6 | -10,025,825.75 | -6,539,200.68 |
| 其中:利息收入 | 3,821,935.81 | 1,886,105.67 | 2,828,961.81 | 2,307,365.65 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | 36,233,619.1 | 19,052,784.16 | 108,578,694.29 | 82,042,245.6 |
| 资产处置收益 | -36,368.8 | 1,131.16 | - | - |
| 信用减值损失(新) | -164,372.92 | -849,758.22 | -642,040.27 | -131,791.86 |
| 其他收益 | 663,002.99 | 396,202.98 | 1,880,037.69 | 1,546,304.35 |
| 四、营业利润 | 66,568,476.94 | 27,889,639.62 | 127,944,255.6 | 85,493,929.39 |
| 加:营业外收入 | 79,271.34 | 21,122.47 | 426,678.1 | 333,769.1 |
| 减:营业外支出 | 32,748.86 | - | 166,576.07 | 84,316.18 |
| 五、利润总额 | 66,614,999.42 | 27,910,762.09 | 128,204,357.63 | 85,743,382.31 |
| 减:所得税费用 | 9,247,149.57 | 3,019,073.41 | 23,253,017.46 | 4,736,208.37 |
| 六、净利润 | 57,367,849.85 | 24,891,688.68 | 104,951,340.17 | 81,007,173.94 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 57,367,849.85 | 24,891,688.68 | 104,951,340.17 | 81,007,173.94 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 57,481,930.48 | 24,913,986.7 | 104,951,340.17 | 81,007,173.94 |
| 少数股东损益 | -114,080.63 | -22,298.02 | - | - |
| 扣除非经常损益后的净利润 | 48,756,638.97 | 20,904,157.75 | 102,481,790.83 | 79,475,689.7 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.29 | 0.12 | 0.52 | 0.4 |
| (二)稀释每股收益 | 0.29 | 0.12 | 0.52 | 0.4 |
| 九、综合收益总额 | 57,367,849.85 | 24,891,688.68 | 104,951,340.17 | 81,007,173.94 |
| 归属于母公司股东的综合收益总额 | 57,481,930.48 | 24,913,986.7 | 104,951,340.17 | 81,007,173.94 |
| 归属于少数股东的综合收益总额 | -114,080.63 | -22,298.02 | - | - |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-29 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |